Literature DB >> 32285113

Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity.

Hiroshi Komatsu1,2, Hikaru Takeuchi3, Yoshie Kikuchi4, Chiaki Ono4, Zhiqian Yu4, Kunio Iizuka5, Yuji Takano6, Yoshihisa Kakuto1, Shunichi Funakoshi1,7, Takashi Ono1, Junko Ito8, Yasuto Kunii9,10, Mizuki Hino9, Atsuko Nagaoka9, Yasushi Iwasaki11, Hidenaga Yamamori12,13, Yuka Yasuda12,13, Michiko Fujimoto13, Hirotsugu Azechi14, Noriko Kudo12,13, Ryota Hashimoto12,13,14, Hirooki Yabe9, Mari Yoshida11, Yuko Saito15, Akiyoshi Kakita8, Nobuo Fuse6, Ryuta Kawashima3,16, Yasuyuki Taki3,6,17, Hiroaki Tomita2,4,5,6.   

Abstract

Previous studies have indicated associations between several OLIG2 gene single-nucleotide polymorphisms (SNPs) and susceptibility to schizophrenia among Caucasians. Consistent with these findings, postmortem brain and diffusion tensor imaging studies have indicated that the schizophrenia-risk-associated allele (A) in the OLIG2 SNP rs1059004 predicts lower OLIG2 gene expression in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia patients and reduced white matter (WM) integrity of the corona radiata in normal brains among Caucasians. In an effort to replicate the association between this variant and WM integrity among healthy Japanese, we found that the number of A alleles was positively correlated with WM integrity in some fiber tracts, including the right posterior limb of the internal capsule, and with mean blood flow in a widespread area, including the inferior frontal operculum, orbital area, and triangular gyrus. Because the A allele affected WM integrity in opposite directions in Japanese and Caucasians, we investigated a possible association between the OLIG2 gene SNPs and the expression level of OLIG2 transcripts in postmortem DLPFCs. We evaluated rs1059004 and additional SNPs in the 5' upstream and 3' downstream regions of rs1059004 to cover the broader region of the OLIG2 gene. The 2 SNPs (rs1059004 and rs9653711) had opposite effects on OLIG2 gene expression in the DLPFC in Japanese and Caucasians. These findings suggest ethnicity-dependent opposite effects of OLIG2 gene SNPs on WM integrity and OLIG2 gene expression in the brain, which may partially explain the failures in replicating associations between genetic variants and psychiatric phenotypes among ethnicities.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 OLIG2 polymorphism; schizophrenia; white matter integrity/cerebral blood flow/OLIG2 gene expression/ethnic difference

Year:  2020        PMID: 32285113      PMCID: PMC7846078          DOI: 10.1093/schbul/sbaa049

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  46 in total

1.  ASSOCIATION STUDY BETWEEN OLIGODENDROCYTE TRANSCRIPTION FACTOR 2 GENE AND OBSESSIVE-COMPULSIVE DISORDER IN A CHINESE HAN POPULATION.

Authors:  Xinhua Zhang; Jie Liu; Yunliang Guo; Weihua Jiang; Jianhua Yu
Journal:  Depress Anxiety       Date:  2015-08-14       Impact factor: 6.505

2.  Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.

Authors:  Robert E McCullumsmith; Daya Gupta; Monica Beneyto; Emily Kreger; Vahram Haroutunian; Kenneth L Davis; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2007-01-12       Impact factor: 4.939

3.  Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template.

Authors:  Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta
Journal:  Neuroimage       Date:  2008-01-03       Impact factor: 6.556

4.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Authors:  Dmitri Tkachev; Michael L Mimmack; Margaret M Ryan; Matt Wayland; Tom Freeman; Peter B Jones; Michael Starkey; Maree J Webster; Robert H Yolken; Sabine Bahn
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

5.  Association of SOX10 with schizophrenia in the Japanese population.

Authors:  Nobuhisa Maeno; Nagahide Takahashi; Shinichi Saito; Xiaofei Ji; Ryoko Ishihara; Nagisa Aoyama; Aleksic Branko; Hideki Miura; Masashi Ikeda; Tatsuyo Suzuki; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Nakao Iwata; Toshiya Inada; Norio Ozaki
Journal:  Psychiatr Genet       Date:  2007-08       Impact factor: 2.458

6.  Risk variant of oligodendrocyte lineage transcription factor 2 is associated with reduced white matter integrity.

Authors:  Diana P Prata; Richard A Kanaan; Gareth J Barker; Sukhwinder Shergill; James Woolley; Lyudmila Georgieva; Marco M Picchioni; Eugenia Kravariti; Muriel Walshe; Matt Allin; Timothea Toulopoulou; Elvira Bramon; Colm McDonald; Vincent Giampietro; Robin M Murray; Michael Brammer; Michael O'Donovan; Philip McGuire
Journal:  Hum Brain Mapp       Date:  2012-04-16       Impact factor: 5.038

7.  Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles.

Authors:  Benjamin P Fairfax; Seiko Makino; Jayachandran Radhakrishnan; Katharine Plant; Stephen Leslie; Alexander Dilthey; Peter Ellis; Cordelia Langford; Fredrik O Vannberg; Julian C Knight
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

8.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.

Authors:  Fanggeng Zou; High Seng Chai; Curtis S Younkin; Mariet Allen; Julia Crook; V Shane Pankratz; Minerva M Carrasquillo; Christopher N Rowley; Asha A Nair; Sumit Middha; Sooraj Maharjan; Thuy Nguyen; Li Ma; Kimberly G Malphrus; Ryan Palusak; Sarah Lincoln; Gina Bisceglio; Constantin Georgescu; Naomi Kouri; Christopher P Kolbert; Jin Jen; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Ronald C Petersen; Neill R Graff-Radford; Dennis W Dickson; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

9.  Pronounced strain-specific chemosensory receptor gene expression in the mouse vomeronasal organ.

Authors:  Kyle Duyck; Vasha DuTell; Limei Ma; Ariel Paulson; C Ron Yu
Journal:  BMC Genomics       Date:  2017-12-12       Impact factor: 3.969

10.  Association between SNPs and gene expression in multiple regions of the human brain.

Authors:  S Kim; H Cho; D Lee; M J Webster
Journal:  Transl Psychiatry       Date:  2012-05-08       Impact factor: 6.222

View more
  4 in total

Review 1.  Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis.

Authors:  Hiroshi Komatsu; Goh Onoguchi; Stefan Jerotic; Nobuhisa Kanahara; Yoshihisa Kakuto; Takashi Ono; Shunichi Funakoshi; Takeshi Yabana; Toru Nakazawa; Hiroaki Tomita
Journal:  Mol Psychiatry       Date:  2022-05-02       Impact factor: 15.992

Review 2.  The Molecular Genetics of Dissociative Symptomatology: A Transdiagnostic Literature Review.

Authors:  Ravi Philip Rajkumar
Journal:  Genes (Basel)       Date:  2022-05-08       Impact factor: 4.141

3.  Transcriptional Profiles of Cell Fate Transitions Reveal Early Drivers of Neuronal Apoptosis and Survival.

Authors:  Giovanna Morello; Ambra Villari; Antonio Gianmaria Spampinato; Valentina La Cognata; Maria Guarnaccia; Giulia Gentile; Maria Teresa Ciotti; Pietro Calissano; Velia D'Agata; Cinzia Severini; Sebastiano Cavallaro
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

Review 4.  Insights into myelin dysfunction in schizophrenia and bipolar disorder.

Authors:  Marcela Valdés-Tovar; Alejandra Monserrat Rodríguez-Ramírez; Leslye Rodríguez-Cárdenas; Carlo E Sotelo-Ramírez; Beatriz Camarena; Marco Antonio Sanabrais-Jiménez; Héctor Solís-Chagoyán; Jesús Argueta; Germán Octavio López-Riquelme
Journal:  World J Psychiatry       Date:  2022-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.